Drugs In R&d

Drugs In R&d

研发中的药物

  • 3区 中科院分区
  • Q3 JCR分区

期刊简介

《Drugs In R&d》是由Springer International Publishing出版社于1999年创办的英文国际期刊(ISSN: 1174-5886,E-ISSN: 1179-6901),该期刊长期致力于药学领域的创新研究,主要研究方向为Pharmacology, Toxicology and Pharmaceutics-Pharmacology。作为SCI、SCIE收录期刊(JCR分区 Q3,中科院 3区),本刊采用OA开放获取模式(OA占比1%),以发表药学领域等方向的原创性研究为核心(研究类文章占比93.33%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在30篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Drugs In R&d审稿周期约为8 Weeks。该刊近年未被列入国际预警名单,年发文量约30篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 30 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 205 / 356

42.6

学科:PHARMACOLOGY & PHARMACY SCIE Q3 211 / 356

40.87

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 204 / 354

42.5

学科:PHARMACOLOGY & PHARMACY SCIE Q2 171 / 354

51.84

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:4 SJR:0.918 SNIP:0.73
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q3 183 / 328

44%

期刊发文

  • Preclinical Evaluation of AHT-102, a CLDN18.2 × CD3 Bispecific Antibody: Pharmacokinetics, Anti-Tumor Efficacy, Tissue Distribution, and Safety Profil

    Author: Chu, Huilun; Xu, Guili; Liu, Yunlong; Qian, Niliang; Li, Yanchuan; Liu, Yujie; Pan, Xiujie; Gao, Xin; Ou, Lun; Lv, Junping; Song, Haifeng

    Journal: DRUGS IN R&D. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40268-026-00535-y

  • Advanced Drug Delivery Strategies for Overcoming Biological Barriers: Tumor Microenvironment and Blood-Brain Barrie

    Author: Lei, Yicong; Xiao, Tingyu; Hu, Xin; Lin, Huaqing

    Journal: DRUGS IN R&D. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40268-026-00538-9

  • Development and Evaluation of Multiple-Unit Tablets for the Controlled Release of Lornoxica

    Author: Liu, Yang; Shi, Qiong-zhi; Wang, Yanchen; Long, Ze-chun; Han, Man; Zeng, Yuan; Xie, Xiang-yang; Liu, Hui

    Journal: DRUGS IN R&D. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40268-026-00540-1

  • Pharmacokinetics and Bioequivalence Evaluation of Piracetam Tablet: A Randomized, Single-Dose, Two-Period, Crossover Study in Healthy Chinese Participants Under Fasting and Fed Condition

    Author: Yan, Hegui; Zhou, Ming; Pan, Zhixiang; Peng, Yu; Wang, Jie; Li, Xiuwen; Xie, Yafang; Liu, Qianying; Huang, Cuiping; Wang, Qiuhong; Liu, Guan

    Journal: DRUGS IN R&D. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40268-026-00541-0

  • Safety Evaluation of Contezolid (MRX-I) Versus Linezolid in Sprague-Dawley Rat

    Author: Wei, Liping; Hong, Min; Lu, Min; Qian, Yimin; Li, Qingmei; Tang, Naping; Li, Hua; Chang, Yan; Qiu, Yunliang

    Journal: DRUGS IN R&D. 2025; Vol. 25, Issue 2, pp. 127-140. DOI: 10.1007/s40268-025-00504-x

  • Analysis of Sirolimus Blood Concentration and Influencing Factors in Pediatric Patients: Implications for Individualized Drug Therap

    Author: Xu, Xiaolin; Mao, Xueting; Liu, Bo; Sun, Yixin; Cheng, Xiaoling; Wang, Xiaoling; Mao, Huawei

    Journal: DRUGS IN R&D. 2025; Vol. 25, Issue 1, pp. 79-88. DOI: 10.1007/s40268-025-00506-9

  • Systematic Review and Meta-analysis of the Clinical Efficacy of Octreotide in Combination with Ulinastatin in the Treatment of Acute Pancreatiti

    Author: Zhu, Long-Xun; Chen, Yong; Chen, Xiang-Fan; Sheng, Nan; Feng, Pan-Feng

    Journal: DRUGS IN R&D. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s40268-025-00518-5

  • Pharmacokinetic Comparison of Novel Tablet-in-Tablet and Conventional Ketorolac Tromethamine Tablets in Beagle Dog

    Author: Xie, Xiang-yang; Zeng, Yuan; Chen, Zhi-long; Li, Yu-liang; Lin, Wen; Liu, Hui; Ma, Yi-hui; Zhang, Guo-wei

    Journal: DRUGS IN R&D. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s40268-025-00516-7